A Study to Evaluate the Combination of Nivolumab With ADG106 in Metastatic NSCLC
Clinical trial NCT05236608 · UNKNOWN
Trial details
- NCT number
- NCT05236608
- Sponsor
- National University Hospital, Singapore
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-12
- Primary completion
- 2024-05-01
- Enrollment
- 53
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.